
### [NCIT:C6588](http://purl.obolibrary.org/obo/NCIT_C6588)
**Label:** Malignant Soft Tissue Tumor of Uncertain Differentiation

**Subclasses:** [NCIT:C9409](http://purl.obolibrary.org/obo/NCIT_C9409) (Epithelioid Sarcoma NCI Grade 2), [NCIT:C27373](http://purl.obolibrary.org/obo/NCIT_C27373) (Adult Desmoplastic Small Round Cell Tumor), [NCIT:C27372](http://purl.obolibrary.org/obo/NCIT_C27372) (Childhood Desmoplastic Small Round Cell Tumor), [NCIT:C7944](http://purl.obolibrary.org/obo/NCIT_C7944) (Adult Epithelioid Sarcoma), [NCIT:C8799](http://purl.obolibrary.org/obo/NCIT_C8799) (Metastatic Epithelioid Sarcoma), [NCIT:C7943](http://purl.obolibrary.org/obo/NCIT_C7943) (Adult Alveolar Soft Part Sarcoma), [NCIT:C8797](http://purl.obolibrary.org/obo/NCIT_C8797) (Primary Alveolar Soft Part Sarcoma), [NCIT:C8798](http://purl.obolibrary.org/obo/NCIT_C8798) (Recurrent Alveolar Soft Part Sarcoma), [NCIT:C8796](http://purl.obolibrary.org/obo/NCIT_C8796) (Metastatic Alveolar Soft Part Sarcoma), [NCIT:C40225](http://purl.obolibrary.org/obo/NCIT_C40225) (Cervical Alveolar Soft Part Sarcoma), [NCIT:C40320](http://purl.obolibrary.org/obo/NCIT_C40320) (Vulvar Alveolar Soft Part Sarcoma), [NCIT:C8803](http://purl.obolibrary.org/obo/NCIT_C8803) (Recurrent Extraskeletal Ewing Sarcoma), [NCIT:C5059](http://purl.obolibrary.org/obo/NCIT_C5059) (Recurrent Epithelioid Sarcoma), [NCIT:C3750](http://purl.obolibrary.org/obo/NCIT_C3750) (Alveolar Soft Part Sarcoma), [NCIT:C8801](http://purl.obolibrary.org/obo/NCIT_C8801) (Metastatic Extraskeletal Ewing Sarcoma), [NCIT:C8802](http://purl.obolibrary.org/obo/NCIT_C8802) (Non-Metastatic Extraskeletal Ewing Sarcoma), [NCIT:C8800](http://purl.obolibrary.org/obo/NCIT_C8800) (Primary Epithelioid Sarcoma), [NCIT:C7135](http://purl.obolibrary.org/obo/NCIT_C7135) (Extraskeletal Ewing Sarcoma), [NCIT:C7596](http://purl.obolibrary.org/obo/NCIT_C7596) (Malignant Myoepithelioma), [NCIT:C8300](http://purl.obolibrary.org/obo/NCIT_C8300) (Desmoplastic Small Round Cell Tumor), [NCIT:C6586](http://purl.obolibrary.org/obo/NCIT_C6586) (Extrarenal Rhabdoid Tumor), [NCIT:C9410](http://purl.obolibrary.org/obo/NCIT_C9410) (Epithelioid Sarcoma NCI Grade 3), [NCIT:C8095](http://purl.obolibrary.org/obo/NCIT_C8095) (Childhood Epithelioid Sarcoma), [NCIT:C8092](http://purl.obolibrary.org/obo/NCIT_C8092) (Childhood Alveolar Soft Part Sarcoma), [NCIT:C121787](http://purl.obolibrary.org/obo/NCIT_C121787) (Malignant Mixed Tumor, Not Otherwise Specified), [NCIT:C40395](http://purl.obolibrary.org/obo/NCIT_C40395) (Malignant Breast Myoepithelioma), [NCIT:C126356](http://purl.obolibrary.org/obo/NCIT_C126356) (Peritoneal Desmoplastic Small Round Cell Tumor), [NCIT:C3714](http://purl.obolibrary.org/obo/NCIT_C3714) (Epithelioid Sarcoma), [NCIT:C96847](http://purl.obolibrary.org/obo/NCIT_C96847) (Extrarenal Rhabdoid Tumor of the Liver), [NCIT:C35700](http://purl.obolibrary.org/obo/NCIT_C35700) (Salivary Gland Myoepithelial Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C53583](http://purl.obolibrary.org/obo/NCIT_C53583) (Tissue Differentiation Uncertain) 58.33%
- [NCIT:C36163](http://purl.obolibrary.org/obo/NCIT_C36163) (Metastatic/Recurrent Disease) 58.33%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 58.33%
- Thing 51.96%
- [NCIT:C12471](http://purl.obolibrary.org/obo/NCIT_C12471) (Soft Tissue) 37.20%
- [NCIT:C12964](http://purl.obolibrary.org/obo/NCIT_C12964) (Connective and Soft Tissue) 30.69%
- [NCIT:C35461](http://purl.obolibrary.org/obo/NCIT_C35461) (Clinical Course of Disease) 28.98%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 28.10%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 27.64%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 20.18%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 20.01%
- [NCIT:C36292](http://purl.obolibrary.org/obo/NCIT_C36292) (Laboratory Test Result) 12.24%
- [NCIT:C77140](http://purl.obolibrary.org/obo/NCIT_C77140) (Clinical Test Result) 12.17%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 11.57%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 9.85%


